Thomas Klag

Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments

Dirk Ehmann, Judith Wendler, Louis Koeninger et al. · Proceedings of the National Academy of Sciences · 2019 · 104 citations · Full text

Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib

Paul La Rosée, Philippe Martiat, Armin Leitner et al. · Annals of Hematology · 2013 · 50 citations

Hematological Malignancy, Oncology, Hematology +6

Quality of life in inflammatory bowel diseases: it is not all about the bowel

Ronald Keller, Nazar Mazurak, Laura Fantasia et al. · Intestinal Research · 2020 · 42 citations · Full text

GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting

Marc Schoeler, Thomas Klag, Judith Wendler et al. · Therapeutic Advances in Gastroenterology · 2018 · 41 citations · Full text

Tacrolimus Suppositories in Therapy-Resistant Ulcerative Proctitis

Simon U. Jaeger, Thomas Klag, Katharina Hoeger et al. · Inflammatory Intestinal Diseases · 2018 · 34 citations · Full text